Washington: Researchers at the Perelman School of Medicine, University of Pennsylvania have identified a key molecular player in recurrent breast cancer - a finding that suggests potential new therapeutic strategies.The study, performed in the laboratory of Lewis A. Chodosh MD, PhD, chair of Cancer Biology and director of Cancer Genetics at the Abramson Family Cancer Research Institute, implicates the tumor suppressor protein Par-4 in recurrent breast cancer.
INS Kuthar mishap: Navy orders probe
TRAI Amendment Bill passed in Lok Sabha
Govt slaps $579 mn additional penalty on RIL
UPSC aspirants protest outside Rajnath Singh`s residence